Tuesday, July 3, 2012

What's new for 'Trypanosomatids' in PubMed

This message contains My NCBI what's new results from the National Center for Biotechnology Information (NCBI) at the U.S. National Library of Medicine (NLM).
Do not reply directly to this message.

Sender's message:

Sent on Tuesday, 2012 July 03
Search: kinetoplastids OR kinetoplastid OR Kinetoplastida OR "trypanosoma brucei" OR leishmania OR brucei OR leishmaniasis OR "African trypanosomiasis"

Click here to view complete results in PubMed (Results may change over time.)
To unsubscribe from these e-mail updates click here.


PubMed Results
Items 1 - 2 of 2

1. Arch Gynecol Obstet. 2012 Apr;285(4):919-23. Epub 2011 Sep 17.

Chagas disease in Latin American pregnant immigrants: experience in a non-endemic country.

Ramos JM, Milla A, Rodríguez JC, López-Chejade P, Flóres M, Rodríguez JM, Gutiérrez F.

Source

Infectious Diseases Unit, Hospital General Universitario de Elche, Elche, Spain. jramosrincon@yahoo.es

Abstract

PURPOSE:

Chagas disease is a systemic chronic parasitic infection by Trypanosoma cruzi endemic in Latin America. Migration of women of childbearing age from Latin America to developed countries may spread the disease to non-endemic areas through vertical transmission.

METHODS:

Prospective study of seroprevalence of T. cruzi infection in immigrant Latin American pregnant women during a 5-year period (from 2006 to 2010) in Spain.

RESULTS:

Seven out of 545 participants were seropositive for T. cruzi [prevalence 1.28%, 95% confidence interval (CI) 0.06-2.56]. Four (57%) were from Bolivia and three (43.%) from Paraguay. The seroprevalence in pregnant women from Bolivia was 10.26% (95% CI 4.06-23.58) and in participants from Paraguay was 6.52% (95% CI 2.24-17.5). No congenital transmission occurred.

CONCLUSIONS:

Seroprevalence of T. cruzi infection in Latin American pregnant women coming from Bolivia and Paraguay is high. Those women should be screened for T. cruzi to control mother-to-child transmission in non-endemic areas.

PMID: 21927962 [PubMed - indexed for MEDLINE]
Related citations
Icon for Springer

2. Braz J Med Biol Res. 2011 Feb;44(2):84-90. Epub 2011 Jan 14.

Evasion of immune responses by Trypanosoma cruzi, the etiological agent of Chagas disease.

DosReis GA.

Source

Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil. gdosreis@biof.ufrj.br

Abstract

Infection with the protozoan parasite Trypanosoma cruzi leads to Chagas disease, which affects millions of people in Latin America. Infection with T. cruzi cannot be eliminated by the immune system. A better understanding of immune evasion mechanisms is required in order to develop more effective vaccines. During the acute phase, parasites replicate extensively and release immunomodulatory molecules that delay parasite-specific responses mediated by T cells. This immune evasion allows the parasite to spread in the host. In the chronic phase, parasite evasion relies on its replication strategy of hijacking the TGF-β signaling pathway involved in inflammation and tissue regeneration. In this article, the mechanisms of immune evasion described for T. cruzi are reviewed.

Free Article
PMID: 21243314 [PubMed - indexed for MEDLINE]
Related citations
Icon for Scientific Electronic Library Online

No comments:

Post a Comment